epithalon every other day Epithalon Peptide: Anti-Aging, Longevity, and
Description
Several companies have GLP-1/glucose-dependent insulinotropic polypeptide (GIP) dual agonists in phase 1 studies, including SCO-094 (Scohia Pharma), VK2735 (Viking Therapeutics) and CT-388 (Carmot Therapeutics)
you have to get it through food or B12 supplements
During this phase, your provider establishes your therapeutic doses based on lab response and symptom improvement
We support a healthy pregnancy
